Podcast Episodes

Sep 29 2023 This Week in Cardiology

Reader feedback, leadless pacing, ABIM, SGLT2 inhibitors, peri-operative MI after cardiac surgery, and. AHA late-breakers are the topics John Mandrol…

2 years, 8 months ago

Sep 22 2023 This Week in Cardiology

Coronary calcium, cardiac arrest survival, Factor XI drug findings, APCs and a potential new board certification in cardiology are the topics discuss…

2 years, 9 months ago

Sep 15 2023 This Week in Cardiology

Reader feedback, imaging in the cath lab, AF ablation to relieve anxiety, and some possible help in hypertension are the topics John Mandrola, MD, di…

2 years, 9 months ago

Sep 08 2023 This Week in Cardiology

ESC Recap Part 2: ECLS-SHOCK, FIRE, MULTISTARS-AMI, HEART FID, and DANPACE II are the trials John Mandrola, MD, discusses in this week's podcast.

Thi…

2 years, 9 months ago

Sep 01 2023 This Week in Cardiology

ESC Wrap-up 1: Obesity, heart failure with preserved EF and reduced EF, AF, frailty, evidence translation, and catheter ablation are the topics John …

2 years, 9 months ago

Aug 25 2023 This Week in Cardiology

GLP-1 agonists in HFpEF, DOACs for subclinical AF, renal denervation, and the matter of remaining in the profession are the topics John Mandrola, MD,…

2 years, 10 months ago

Aug 18 2023 This Week in Cardiology

ICD generator change, less is more in VT management, co-morbidity in HF, and SGLT2i after AF ablation are the topics discussed by John Mandrola, MD, …

2 years, 10 months ago

Aug 11, 2023 This Week in Cardiology Podcast

Observational studies, another defense of digoxin, CTO-PCI, BP measurement, and a possible revolution in cardiovascular protection are the topics Joh…

2 years, 10 months ago

Aug 04 2023 This Week in Cardiology

Listener feedback re observational studies, surgeons' dissent from recent guidelines, aspirin for primary prevention, and fish oil are the topics dis…

2 years, 10 months ago

Jul 28 2023 This Week in Cardiology

Antiarrhythmic drugs in patients with CAD, observational studies, GLP-1 agonists, and the subcutaneous ICD are the topics John Mandrola, MD, discusse…

2 years, 10 months ago